| abstract |
The present invention relates to formula (I): Novel benzoylurea derivatives, and optical enantiomers, racemates and salts thereof, are very effective and selective antagonists of the NMDA receptor, and in addition, most of the compounds are NMDA receptor Provided to be a selective antagonist of the NR2B subtype. The present invention further provides a pharmaceutical composition containing a novel benzoylurea derivative of formula (I), or an optical enantiomer, racemate, or salt thereof as an active ingredient, and a method for producing the compound and the pharmaceutical composition. Also provide. |